Clinical trial

A Pilot Study for the Treatment of Iris Neovascularization With Macugen

NCT00295828

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-01-01

PhasePHASE1

Study timeline

Study start (unknown)2006-01-01Date precision: month

Registry last updated2008-09-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Iris Neovascularizationunresolved

Diabetic Retinopathyunresolved

Interventions

Pegaptanib Sodium Injection/Panretinal PhotocoagulationOTHER

Panretinal Photocoagulation (PRP)PROCEDURE

Sponsors & collaborators

Hermann Eye Centerlead sponsor

Eyetech Pharmaceuticalscollaborator

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00295828 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.